Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China
· Delayed Price · Currency is CNY 8.81
+0.04 (0.46%)
Apr 29, 2026, 3:04 PM CST
SHE:002332 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 3,669 | 3,759 | 3,980 | 4,079 | 4,358 | 4,335 | Upgrade
|
| Other Revenue | - | - | 21.17 | 43.96 | 21.52 | 22.46 | Upgrade
|
| Revenue | 3,669 | 3,759 | 4,001 | 4,123 | 4,380 | 4,357 | Upgrade
|
| Revenue Growth (YoY) | -7.60% | -6.04% | -2.98% | -5.85% | 0.52% | 8.42% | Upgrade
|
| Cost of Revenue | 1,381 | 1,459 | 1,744 | 1,972 | 1,865 | 1,848 | Upgrade
|
| Gross Profit | 2,288 | 2,300 | 2,256 | 2,152 | 2,515 | 2,509 | Upgrade
|
| Selling, General & Admin | 1,538 | 1,498 | 1,344 | 1,271 | 1,532 | 1,560 | Upgrade
|
| Research & Development | 301.98 | 303.75 | 265.17 | 261 | 266.77 | 243.37 | Upgrade
|
| Other Operating Expenses | 2.96 | 8.3 | 19.26 | 22.04 | 32.92 | 32.73 | Upgrade
|
| Operating Expenses | 1,843 | 1,810 | 1,639 | 1,547 | 1,836 | 1,836 | Upgrade
|
| Operating Income | 445.31 | 490.12 | 617.42 | 604.79 | 678.81 | 672.92 | Upgrade
|
| Interest Expense | - | - | -3.13 | -3.37 | -6.29 | -23.1 | Upgrade
|
| Interest & Investment Income | - | - | 29.48 | 38.28 | 76.54 | 43.19 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 10.57 | -9.32 | 11.8 | 17.44 | Upgrade
|
| Other Non Operating Income (Expenses) | 59.19 | 64.04 | -2.7 | -5.53 | -11.25 | -5.26 | Upgrade
|
| EBT Excluding Unusual Items | 510.28 | 554.17 | 651.63 | 624.85 | 749.6 | 705.19 | Upgrade
|
| Gain (Loss) on Sale of Investments | -31.98 | -26.41 | -8.14 | -8.97 | -0 | 0.64 | Upgrade
|
| Gain (Loss) on Sale of Assets | 46.18 | 46.3 | 0.28 | -1.48 | 91.62 | 14.51 | Upgrade
|
| Asset Writedown | -38.21 | -38.21 | -1.31 | -0.42 | -0.91 | -1.68 | Upgrade
|
| Other Unusual Items | - | - | -170.81 | 27.7 | 31.58 | 11.2 | Upgrade
|
| Pretax Income | 486.26 | 535.84 | 498.33 | 641.68 | 871.89 | 729.87 | Upgrade
|
| Income Tax Expense | 81.46 | 83.24 | 98.4 | 79.56 | 124.49 | 108.6 | Upgrade
|
| Earnings From Continuing Operations | 404.81 | 452.6 | 399.92 | 562.12 | 747.4 | 621.26 | Upgrade
|
| Minority Interest in Earnings | -5.27 | -2.96 | -2.74 | 0.97 | 2.01 | -1.94 | Upgrade
|
| Net Income | 399.54 | 449.64 | 397.18 | 563.08 | 749.41 | 619.33 | Upgrade
|
| Net Income to Common | 399.54 | 449.64 | 397.18 | 563.08 | 749.41 | 619.33 | Upgrade
|
| Net Income Growth | 2.44% | 13.21% | -29.46% | -24.86% | 21.00% | 22.76% | Upgrade
|
| Shares Outstanding (Basic) | 999 | 999 | 993 | 988 | 989 | 989 | Upgrade
|
| Shares Outstanding (Diluted) | 999 | 999 | 993 | 988 | 989 | 989 | Upgrade
|
| Shares Change (YoY) | 0.64% | 0.63% | 0.51% | -0.13% | 0.00% | 7.84% | Upgrade
|
| EPS (Basic) | 0.40 | 0.45 | 0.40 | 0.57 | 0.76 | 0.63 | Upgrade
|
| EPS (Diluted) | 0.40 | 0.45 | 0.40 | 0.57 | 0.76 | 0.63 | Upgrade
|
| EPS Growth | 1.78% | 12.50% | -29.83% | -24.76% | 21.00% | 13.84% | Upgrade
|
| Free Cash Flow | 181.24 | 38.4 | 191.07 | 360.85 | 326.74 | 409.31 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.04 | 0.19 | 0.36 | 0.33 | 0.41 | Upgrade
|
| Dividend Per Share | - | - | 0.300 | 0.300 | 0.300 | 0.150 | Upgrade
|
| Dividend Growth | - | - | - | - | 100.00% | - | Upgrade
|
| Gross Margin | 62.36% | 61.19% | 56.40% | 52.18% | 57.42% | 57.58% | Upgrade
|
| Operating Margin | 12.14% | 13.04% | 15.43% | 14.67% | 15.50% | 15.44% | Upgrade
|
| Profit Margin | 10.89% | 11.96% | 9.93% | 13.66% | 17.11% | 14.21% | Upgrade
|
| Free Cash Flow Margin | 4.94% | 1.02% | 4.78% | 8.75% | 7.46% | 9.39% | Upgrade
|
| EBITDA | 663.17 | 707.98 | 835.24 | 816.24 | 866.26 | 857.11 | Upgrade
|
| EBITDA Margin | 18.07% | 18.83% | 20.88% | 19.79% | 19.78% | 19.67% | Upgrade
|
| D&A For EBITDA | 217.86 | 217.85 | 217.82 | 211.45 | 187.46 | 184.19 | Upgrade
|
| EBIT | 445.31 | 490.12 | 617.42 | 604.79 | 678.81 | 672.92 | Upgrade
|
| EBIT Margin | 12.14% | 13.04% | 15.43% | 14.67% | 15.50% | 15.44% | Upgrade
|
| Effective Tax Rate | 16.75% | 15.53% | 19.75% | 12.40% | 14.28% | 14.88% | Upgrade
|
| Revenue as Reported | - | - | 4,001 | 4,123 | 4,380 | 4,357 | Upgrade
|
| Advertising Expenses | - | - | 712.54 | 685.06 | 991.03 | 1,035 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.